Filing Flows › GeoVax Labs (GOVX) › Q1 2025 › vs Q4 2024
GeoVax Labs (GOVX) Q1 2025 vs Q4 2024 (quarter over quarter)
GeoVax Labs's revenue rose $772K (+89%) from $864K in Q4 2024 to $1.6M in Q1 2025.
GeoVax Labs, Q1 2025: revenue $1.6M, operating margin -330.2%, net loss $5.4M, operating cash flow −$6.0M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $1.6M | $864K | $772K | +89% |
| Other income, net | $48K | $82K | −$34K | -42% |
| Net loss | $5.4M | $8.3M | −$2.9M | -35% |
| Costs & expenses | $7.0M | $9.2M | −$2.2M | -24% |
| Operating costs | $7.0M | $9.2M | −$2.2M | -24% |
| Research & development | $5.4M | $7.6M | −$2.3M | -30% |
| General & admin | $1.7M | $1.6M | $87K | +5% |
| Operating cash sources | $6.3M | $7.9M | −$1.6M | -21% |
| Depreciation & amortization | $17K | $22K | −$5K | -22% |
| Share-based compensation | $293K | $139K | $153K | +110% |
| Cash used in operations | $6.0M | $7.8M | −$1.8M | -23% |
| Net loss absorbed | $5.4M | $8.3M | −$2.9M | -35% |
| Working capital & other | $918K | −$348K | $1.3M | — |
Questions
How much did GeoVax Labs's revenue grow quarter over quarter in Q1 2025?
GeoVax Labs's revenue rose $772K (+89%) from $864K in Q4 2024 to $1.6M in Q1 2025.